Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rangering i aksjer #40620
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aksjekurs
$1.06
Sist synkronisert: 2021-06-25
Markedsverdi
$110.93K
Endring (1 dag)
-5.36%
Endring (1 år)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Kategori

Pris MLND pris med markedsverdi på B
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
$1.06
Markedsverdi av Millendo Therapeutics, Inc.(MLND)
Markedsverdi: $110.93K
Per August 2026 har Millendo Therapeutics, Inc. en markedsverdi på $110.93K. Dette gjør Millendo Therapeutics, Inc. til det 40620th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Millendo Therapeutics, Inc. fra 2018 til 2026
MLND sammenlignet med topp 5 mest populære stocks
Pris på MLND Eiendel B Markedsverdi for B Resultater
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$52,228,960 $110.93K
$5.466T +4,927,260,279.94%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$42,596,687 $110.93K
$4.458T +4,018,555,252.36%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$39,895,575 $110.93K
$4.175T +3,763,733,361.94%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$35,055,814 $110.93K
$3.669T +3,307,152,137.52%
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
$27,266,235 $110.93K
$2.853T +2,572,286,234.62%